ly 255283 has been researched along with transforming growth factor beta in 1 studies
Studies (ly 255283) | Trials (ly 255283) | Recent Studies (post-2010) (ly 255283) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
---|---|---|---|---|---|
54 | 0 | 15 | 49,119 | 560 | 17,610 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choi, JA; Kim, H; Kim, JH | 1 |
1 other study(ies) available for ly 255283 and transforming growth factor beta
Article | Year |
---|---|
Ras promotes transforming growth factor-β (TGF-β)-induced epithelial-mesenchymal transition via a leukotriene B4 receptor-2-linked cascade in mammary epithelial cells.
Topics: Breast Neoplasms; Cell Line; Epithelial-Mesenchymal Transition; Female; Humans; Mammary Glands, Human; NADPH Oxidase 1; NADPH Oxidases; NF-kappa B; Proto-Oncogene Proteins p21(ras); Reactive Oxygen Species; Receptors, Leukotriene B4; RNA, Small Interfering; Signal Transduction; Tetrazoles; Transforming Growth Factor beta | 2014 |